These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 19412570)
1. Increased K-ras mutation and expression of S100A4 and MUC2 protein in the malignant intraductal papillary mucinous tumor of the pancreas. Jang JY; Park YC; Song YS; Lee SE; Hwang DW; Lim CS; Lee HE; Kim WH; Kim SW J Hepatobiliary Pancreat Surg; 2009; 16(5):668-74. PubMed ID: 19412570 [TBL] [Abstract][Full Text] [Related]
2. K-Ras and microsatellite marker analysis of fine-needle aspirates from intraductal papillary mucinous neoplasms of the pancreas. Schoedel KE; Finkelstein SD; Ohori NP Diagn Cytopathol; 2006 Sep; 34(9):605-8. PubMed ID: 16900481 [TBL] [Abstract][Full Text] [Related]
4. Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas. Ishida M; Egawa S; Aoki T; Sakata N; Mikami Y; Motoi F; Abe T; Fukuyama S; Sunamura M; Unno M; Moriya T; Horii A; Furukawa T Pancreas; 2007 Nov; 35(4):348-52. PubMed ID: 18090241 [TBL] [Abstract][Full Text] [Related]
5. Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype. Ideno N; Ohtsuka T; Kono H; Fujiwara K; Oda Y; Aishima S; Ito T; Ishigami K; Tokunaga S; Ohuchida K; Takahata S; Nakamura M; Mizumoto K; Tanaka M Ann Surg; 2013 Jul; 258(1):141-51. PubMed ID: 23532108 [TBL] [Abstract][Full Text] [Related]
6. P53 mutation but not p16/MTS1 mutation occurs in intraductal papillary mucinous tumors of the pancreas. Mueller J; Gansauge S; Mattfeldt T Hepatogastroenterology; 2003; 50(50):541-4. PubMed ID: 12749268 [TBL] [Abstract][Full Text] [Related]
7. Minimally invasive intraductal papillary-mucinous carcinoma of the pancreas: clinicopathologic study of 104 intraductal papillary-mucinous neoplasms. Nara S; Shimada K; Kosuge T; Kanai Y; Hiraoka N Am J Surg Pathol; 2008 Feb; 32(2):243-55. PubMed ID: 18223327 [TBL] [Abstract][Full Text] [Related]
8. Treatment strategy for intraductal papillary mucinous neoplasm of the pancreas based on malignant predictive factors. Hirono S; Tani M; Kawai M; Ina S; Nishioka R; Miyazawa M; Fujita Y; Uchiyama K; Yamaue H Arch Surg; 2009 Apr; 144(4):345-9; discussion 349-50. PubMed ID: 19380648 [TBL] [Abstract][Full Text] [Related]
9. Characterization of K-ras gene mutations in association with mucinous hypersecretion in intraductal papillary-mucinous neoplasms. Kobayashi N; Inamori M; Fujita K; Fujisawa T; Fujisawa N; Takahashi H; Yoneda M; Abe Y; Kawamura H; Shimamura T; Kirikoshi H; Kubota K; Sakaguchi T; Saito S; Saubermann LJ; Nakajima A J Hepatobiliary Pancreat Surg; 2008; 15(2):169-77. PubMed ID: 18392710 [TBL] [Abstract][Full Text] [Related]
10. Pancreatic juice cytology and subclassification of intraductal papillary mucinous neoplasms of the pancreas. Hibi Y; Fukushima N; Tsuchida A; Sofuni A; Itoi T; Moriyasu F; Mukai K; Aoki T Pancreas; 2007 Mar; 34(2):197-204. PubMed ID: 17312458 [TBL] [Abstract][Full Text] [Related]
11. Single-institution validation of the international consensus guidelines for treatment of branch duct intraductal papillary mucinous neoplasms of the pancreas. Nagai K; Doi R; Ito T; Kida A; Koizumi M; Masui T; Kawaguchi Y; Ogawa K; Uemoto S J Hepatobiliary Pancreat Surg; 2009; 16(3):353-8. PubMed ID: 19280108 [TBL] [Abstract][Full Text] [Related]
13. Clonality and K-ras mutation analyses of epithelia in intraductal papillary mucinous tumor and mucinous cystic tumor of the pancreas. Yoshizawa K; Nagai H; Sakurai S; Hironaka M; Morinaga S; Saitoh K; Fukayama M Virchows Arch; 2002 Nov; 441(5):437-43. PubMed ID: 12447672 [TBL] [Abstract][Full Text] [Related]
14. Management of intraductal papillary-mucinous neoplasm of the pancreas: treatment strategy based on morphologic classification. Serikawa M; Sasaki T; Fujimoto Y; Kuwahara K; Chayama K J Clin Gastroenterol; 2006 Oct; 40(9):856-62. PubMed ID: 17016145 [TBL] [Abstract][Full Text] [Related]
15. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. Wada K J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900 [TBL] [Abstract][Full Text] [Related]
16. The expression of several types of mucin is related to the biological behavior of pancreatic neoplasms. Yonezawa S; Nakamura A; Horinouchi M; Sato E J Hepatobiliary Pancreat Surg; 2002; 9(3):328-41. PubMed ID: 12353144 [TBL] [Abstract][Full Text] [Related]
17. Endoscopic ultrasound-guided fine-needle aspiration cytology in the diagnosis of intraductal papillary mucinous neoplasms of the pancreas. A study of 8 cases. Salla C; Chatzipantelis P; Konstantinou P; Karoumpalis I; Sakellariou S; Pantazopoulou A; Manika Z JOP; 2007 Nov; 8(6):715-24. PubMed ID: 17993724 [TBL] [Abstract][Full Text] [Related]
18. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas. Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573 [TBL] [Abstract][Full Text] [Related]
19. Surgical outcomes of noninvasive and minimally invasive intraductal papillary-mucinous neoplasms of the pancreas. Takahashi H; Nakamori S; Nakahira S; Tsujie M; Takahshi Y; Marubashi S; Miyamoto A; Takeda Y; Nagano H; Dono K; Umeshita K; Sakon M; Monden M Ann Surg Oncol; 2006 Jul; 13(7):955-60. PubMed ID: 16788757 [TBL] [Abstract][Full Text] [Related]
20. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]